HKSE - Delayed Quote • HKD
The United Laboratories International Holdings Limited (3933.HK)
At close: 4:08 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
2,568,462.000
2,030,543.000
1,542,551.000
1,567,826.000
Investing Cash Flow
-850,950.000
-594,919.000
-587,224.000
166,759.000
Financing Cash Flow
-1,010,653.000
-24,166.000
-620,926.000
-1,907,599.000
End Cash Position
4,744,815.000
4,743,071.000
3,331,009.000
2,996,802.000
Capital Expenditure
-945,121.000
-818,459.000
-487,332.000
-537,570.000
Issuance of Capital Stock
53,001.000
40,164.000
9,359.000
1,436.000
Issuance of Debt
3,334,467.000
2,951,824.000
1,394,373.000
2,406,098.000
Repayment of Debt
-4,022,643.000
-2,623,646.000
-1,709,168.000
-4,061,196.000
Repurchase of Capital Stock
-1,593.000
-42,044.000
-40,978.000
--
Free Cash Flow
1,623,341.000
1,212,084.000
1,055,219.000
1,030,256.000
12/31/2020 - 6/15/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0013.HK HUTCHMED (China) Limited
29.300
+3.35%
0867.HK China Medical System Holdings Limited
7.030
-0.99%
2005.HK SSY Group Limited
4.760
+1.49%
3320.HK China Resources Pharmaceutical Group Limited
4.880
+2.52%
INNO.CN InnoCan Pharma Corporation
0.2750
-3.51%
CRON.TO Cronos Group Inc.
3.4100
+0.29%
OGI.TO Organigram Holdings Inc.
2.6600
-0.75%
CRON Cronos Group Inc.
2.4800
+0.40%
VTRS Viatris Inc.
11.55
+1.67%
TEVA Teva Pharmaceutical Industries Limited
13.01
0.00%